DermConsult
There’s a lot dermatology specialists need to consider when ensuring patients have healthy skin. And at a time when clinical research is increasingly defining skin conditions—and the practice of dermatology itself—as “more than skin deep,” turn to DermConsult.
In this special series, dermatology specialists share their expert advice on the diagnosis and treatment of a variety of skin conditions. They also explore the latest clinical research and their very own case studies, so you can rest assured you’ll have access to everything you need to know about the body’s largest organ.
61-75 of 184

Advancing Alopecia Care: The Changing Treatment Landscape
DermConsultAdvancing Alopecia Care: The Changing Treatment Landscape

Rethinking Quality-of-Life Tools for Psoriasis Patients with Skin of Color
DermConsultRethinking Quality-of-Life Tools for Psoriasis Patients with Skin of Color

The Challenges of Diagnosing Eczematous Dermatitis
DermConsultThe Challenges of Diagnosing Eczematous Dermatitis

Balancing Clinical and Patient-Reported Outcomes in Psoriasis
DermConsultBalancing Clinical and Patient-Reported Outcomes in Psoriasis

How Can We Make Psoriasis Research More Equitable?
DermConsultHow Can We Make Psoriasis Research More Equitable?
- advertisement

Monitoring Patients with Psoriasis: Considerations Beyond Disease Control
DermConsultMonitoring Patients with Psoriasis: Considerations Beyond Disease Control

How to Evaluate Scarring and Non-Scarring Alopecia
DermConsultHow to Evaluate Scarring and Non-Scarring Alopecia

The Future of Psoriasis Care: Novel Therapies and Earlier Intervention
DermConsultThe Future of Psoriasis Care: Novel Therapies and Earlier Intervention
- advertisement

Future Directions in Hair Loss Research and Therapeutics
DermConsultFuture Directions in Hair Loss Research and Therapeutics

Personalizing Treatment in Moderate-to-Severe Psoriasis
DermConsultPersonalizing Treatment in Moderate-to-Severe Psoriasis

BE RADIANT: Long-Term Psoriasis Outcomes with Dual Inhibition
DermConsultBE RADIANT: Long-Term Psoriasis Outcomes with Dual Inhibition




























